Neuroimmunology disorders are conditions where the body’s own immune system mistakenly attacks parts of the
brain, spinal cord, optic nerves, or peripheral nerves. The most well-known are Multiple Sclerosis (MS) and
Neuromyelitis Optica Spectrum Disorder (NMOSD), but there are many others (MOGAD, autoimmune encephalitis, CNS
vasculitis, etc.). These illnesses can cause vision loss, weakness, imbalance, numbness, bladder issues, or
cognitive and behavioural changes. The good news: with today’s treatments, early diagnosis and timely
immunotherapy can significantly reduce relapses and long-term disability. At Vishwalata NeuroConnect, Navi
Mumbai, our Neuroimmunology Clinic focuses on accurate diagnosis, individualized disease-modifying therapy
(DMT), and long-term monitoring for patients with MS, NMOSD and related conditions.
Understanding Neuroimmunology, MS & NMOSD
In simple terms, MS, NMOSD and similar diseases are “misdirected immunity” conditions. Instead of only
fighting infections, the immune system attacks parts of the nervous system:
In Multiple Sclerosis, the immune system attacks myelin (the insulating coating around nerve fibres) in the
brain and spinal cord, causing scattered “plaques” or lesions. This can lead to symptoms like blurred or
double vision, limb weakness, numbness, imbalance, fatigue, and sometimes bladder or cognitive problems. MS
usually follows a relapsing-remitting course (attacks followed by partial recovery) or a more gradual
progressive course.
In NMOSD, the immune system often forms antibodies against aquaporin-4 (AQP4), targeting the optic nerves
and spinal cord. Patients typically have severe episodes of optic neuritis (painful vision loss) or
transverse myelitis (sudden leg weakness, sensory level, bladder involvement).
MOGAD (MOG-antibody disease), autoimmune encephalitis, and other neuroimmune diseases can cause seizures,
behavioural change, memory issues, and focal neurological deficits.
These conditions can be frightening, but they are treatable. Modern disease-modifying drugs and targeted
immunotherapies have transformed the long-term outlook for many patients, especially when started early and
monitored carefully.
Clinical Insights (Etiology, Management & Lifestyle)
MS is a chronic, immune-mediated demyelinating disease of the CNS with both genetic and
environmental risk factors (vitamin D deficiency, infections like EBV, smoking, obesity, etc.).
NMOSD is frequently associated with AQP4-IgG antibodies, while MOGAD is associated with MOG-IgG
antibodies; both are distinct from classical MS in pathology, prognosis, and treatment.
Autoimmune encephalitis (e.g., anti-NMDA receptor, LGI1, CASPR2, GAD65) involves antibodies
against neuronal surface or intracellular antigens, often associated with psychiatric symptoms and
seizures.
- Detailed history (relapses, timeline, visual/spinal/brainstem symptoms), neurological exam
- MRI brain & spinal cord with contrast - to look for demyelinating lesions, longitudinally extensive myelitis, etc.
- CSF analysis - oligoclonal bands (for MS), inflammatory markers, ruling out infections
- Serum antibody panels - AQP4-IgG, MOG-IgG, autoimmune encephalitis antibodies where indicated
- Screening for systemic autoimmune disease (ANA, ENA), infections, nutritional and metabolic causes
- Acute relapse treatment
High-dose IV methylprednisolone 3 – 5 days; if poor response in severe attacks, consider plasma
exchange / IVIG as per guidelines.
- Long-term disease-modifying therapy (DMT)
MS: platform therapies (interferons, glatiramer acetate), oral DMTs (e.g., dimethyl fumarate,
teriflunomide, S1P modulators), and high-efficacy monoclonals (e.g., ocrelizumab, natalizumab,
ofatumumab, alemtuzumab) selected based on disease activity, MRI load, patient profile, pregnancy
plans, etc.
NMOSD: long-term relapse prevention with agents such as rituximab, mycophenolate, azathioprine, or
newer biologics targeting complement or IL-6 pathway, plus careful infection prophylaxis and
monitoring.
MOGAD and other antibody-mediated conditions: often require tailored immunotherapy (steroids,
IVIG, plasma exchange, steroid-sparing agents) based on relapse pattern.
- Spasticity, fatigue, neuropathic pain, bladder dysfunction, mood and cognitive issues managed with meds and physio/occupational therapy.
- Gait training, balance work, and assistive devices when needed.
- Lifestyle & preventive strategies
- Regular exercise within tolerance, healthy weight, smoking cessation, vitamin D optimisation, good sleep hygiene.
- Vaccination planning before potent immunosuppression, infection surveillance, and regular blood monitoring.
- Heat management (for MS), energy conservation, and pacing to prevent over-fatigue.
Red Flags - When to Seek a Neuroimmunology Opinion
Book an urgent or early consultation if you notice:
- Sudden vision loss or blurred vision in one eye, especially with eye pain (possible optic neuritis).
- New limb weakness, numbness or imbalance lasting more than 24 hours without obvious cause.
- Band-like tightness around chest/abdomen, sensory level, or bladder symptoms suggesting myelitis.
- Recurrent episodes of neurological symptoms that improve then recur (relapses) - e.g., previous optic neuritis or spinal attacks.
- New seizures, behavioural change, hallucinations, or confusion with suspected autoimmune encephalitis.
- MRI or report already mentioning “demyelinating lesions, suggestive of MS / demyelination / NMO / ADEM” and you need a specialist opinion.
Any rapidly progressive neurological deficit (vision, limb power, walking, consciousness) should be treated
as an emergency and assessed immediately in a hospital setting.
Why Choose Vishwalata NeuroConnect for MS, NMOSD & Neuroimmunology?
Dedicated Neuroimmunology expertise
Consultant neurologist with a strong interest in MS, NMOSD and demyelinating disorders, familiar with contemporary diagnostic criteria and treatment algorithms.
Comprehensive evaluation
Detailed history, focused examination, review of MRI/CSF/antibody reports, and guidance on further targeted investigations if needed.
Individualised disease
Modifying therapy planning - Step-wise or early high-efficacy strategies depending on disease activity, comorbidities, and patient preferences, with clear risk–benefit discussions.
Structured long-term follow-up
Regular monitoring for relapses, MRI activity, treatment side-effects, infections and vaccination status; timely adjustment of therapy.
Rehabilitation & lifestyle integration
Coordination with physiotherapy, occupational therapy and counselling to address gait, fatigue, cognition and mood; advice on work, pregnancy, travel and daily living with MS/NMOSD.
Patient & family education
Simple explanations, written plans, and ongoing support so patients feel empowered rather than fearful of their diagnosis.